Home › Companies › BIO-TECHNE CORP. › 2023-2024

BIO-TECHNE CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and BIO-TECHNE CORP.’s Form 8-K, filed October 31, 2023 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 14Reported items
  • 574Asset managers
  • 9,959Fund votes
  • October 26, 2023Meeting date

Results at a glance

Meeting of October 26, 2023: 12 items on BIO-TECHNE CORP.’s Form 8-K, filed October 31, 2023: 9 elected · 1 approved · 1 not approved · 1 without a stated outcome.

Not approved or not elected

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIO-TECHNE CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BIO-TECHNE CORP.

These tallies are BIO-TECHNE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed October 31, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIO-TECHNE CORP. — official shareholder meeting results, meeting held October 26, 2023
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
1. The shareholders voted to set the number of directors at nine 141,242,833672,91934,066 ---- 99.5%Not verified—
Elect Director: Robert V. Baumgartner 100,149,01341,734,41566,390 --4,068,045 71%Elected—
Elect Director: Julie L. Bushman 132,251,0879,638,36960,362 --4,068,045 93%Elected—
Elect Director: John L. Higgins 116,991,41624,891,09467,308 --4,068,045 82%Elected—
Elect Director: Joseph D. Keegan 134,547,6667,343,70158,451 --4,068,045 95%Elected—
Elect Director: Charles R. Kummeth 139,037,6622,847,75664,400 --4,068,045 98%Elected—
Elect Director: Roeland Nusse 136,502,0965,384,16463,558 --4,068,045 96%Elected—
Elect Director: Alpna Seth 134,785,9527,102,98560,881 --4,068,045 95%Elected—
Elect Director: Randolph C. Steer 116,461,35725,398,61389,848 --4,068,045 82%Elected—
Elect Director: Rupert Vessey 134,555,0987,335,53459,186 --4,068,045 95%Elected—
Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement: 49,894,29591,277,734777,789 --4,068,045 35%Not approved—
5. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024 140,734,6765,247,72135,466 ---- 96%Approved—

Source: BIO-TECHNE CORP., Form 8-K, filed with the SEC on October 31, 2023 — read the filing on EDGAR.

How asset managers voted at the BIO-TECHNE CORP. 2023-2024 meeting

Each item below shows how the 574 asset managers that disclosed a BIO-TECHNE CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIO-TECHNE CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Alpna Seth

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 134,785,952AGAINST: 7,102,985
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Alpna Seth

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Alpna Seth”): 134,785,952 for, 7,102,985 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Alpna Seth” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS0735,794 00Against
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 87,535,023 for, 1,016,475 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Alpna Seth” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

2. Elect Director: Charles R. Kummeth

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 139,037,662AGAINST: 2,847,756
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Charles R. Kummeth

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Charles R. Kummeth”): 139,037,662 for, 2,847,756 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Charles R. Kummeth” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 88,469,497 for, 82,001 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Charles R. Kummeth” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

3. Elect Director: John L. Higgins

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST
FOR: 116,991,416AGAINST: 24,891,094
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: John L. Higgins

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: John L. Higgins”): 116,991,416 for, 24,891,094 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: John L. Higgins” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock09,533,684 00Against
Fidelity5,215,71683,037 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS0735,794 00Against
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 77,315,694 for, 11,235,804 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: John L. Higgins” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

4. Elect Director: Joseph D. Keegan

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 134,547,666AGAINST: 7,343,701
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Joseph D. Keegan

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Joseph D. Keegan”): 134,547,666 for, 7,343,701 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Joseph D. Keegan” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab01,400,493 00Against
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00Mixed
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 75,305,011 for, 13,246,487 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Joseph D. Keegan” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

5. Elect Director: Julie L. Bushman

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 132,251,087AGAINST: 9,638,369
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Julie L. Bushman

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Julie L. Bushman”): 132,251,087 for, 9,638,369 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Julie L. Bushman” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00Mixed
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 76,710,503 for, 11,840,995 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Julie L. Bushman” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.01,476,403 00Against
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 210 for, 1,476,403 against.

6. Elect Director: Randolph C. Steer

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST
FOR: 116,461,357AGAINST: 25,398,613
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Randolph Steer

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Randolph C. Steer”): 116,461,357 for, 25,398,613 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Randolph Steer” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock09,533,684 00Against
Fidelity5,215,71683,037 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab01,400,493 00Against
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00Mixed
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 65,044,073 for, 23,507,425 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Randolph Steer” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

7. Elect Director: Robert V. Baumgartner

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%AGAINST
FOR: 100,149,013AGAINST: 41,734,415
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Robert V. Baumgartner

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Robert V. Baumgartner”): 100,149,013 for, 41,734,415 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 71% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Robert V. Baumgartner” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock09,533,684 00Against
Fidelity5,215,71683,037 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle02,340,399 00Against
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street01,608,405 00Against
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed01,256,313 00Against
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS0735,794 00Against
BNY Mellon0678,571 00Against
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide565,11612,400 00For

Fund voting reports, all 147 managers: 59,368,971 for, 29,182,527 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Robert V. Baumgartner” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.01,476,403 00Against
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 210 for, 1,476,403 against.

8. Elect Director: Roeland Nusse

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 136,502,096AGAINST: 5,384,164
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Roeland Nusse

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Roeland Nusse”): 136,502,096 for, 5,384,164 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Roeland Nusse” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 88,466,620 for, 84,878 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Roeland Nusse” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

9. Elect Director: Rupert Vessey

Official resultFund totals may overlapDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 134,555,098AGAINST: 7,335,534
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors: Rupert Vessey

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Rupert Vessey”): 134,555,098 for, 7,335,534 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal No. 2 – The shareholders elected each of the nominees to the Board of Directors: Each nominee was elected by a majority voting standard defined in the Amended and Restated Articles of Incorporation.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Election of Directors: Rupert Vessey” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab01,400,493 00Against
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00Mixed
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 75,305,011 for, 13,246,487 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Election of Directors: Rupert Vessey” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

10. 1. The shareholders voted to set the number of directors at nine

Outcome not verifiedFund totals may overlapCORPORATE GOVERNANCEReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 141,242,833AGAINST: 672,919
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: To set the number of Directors at nine.

BIO-TECHNE CORP.’s own tally for this item (“1. The shareholders voted to set the number of directors at nine”): 141,242,833 for, 672,919 against, per its Form 8-K filed October 31, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “To set the number of Directors at nine.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 88,547,263 for, 4,235 against, 11,964 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “To set the number of Directors at nine.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

11. Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not approved

Combines 6 wordings of this item as funds reported it.

35% Not approved · of votes cast

FOR 35%AGAINST
FOR: 49,894,295AGAINST: 91,277,734
Details: description as filed, official tally, votes by 531 asset managers

Description as filed by funds: APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS.

BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 49,894,295 for, 91,277,734 against — failed, per its Form 8-K filed October 31, 2023 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “Proposal No. 3 – The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”
Support: 35% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIO-TECHNE CORP.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION” (20 managers, 337,789 for, 2,351,036 against); “14A Executive Compensation” (8 managers, 3,085 for, 156,315 against); “Approve, on an advisory basis, the H of our executive officers.” (2 managers, 12,698 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 146 asset managers voting on “APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard17,780,1771,462,345 00Mixed
WisdomTree32,62611,058,577 00Against
BlackRock09,533,684 00Against
Fidelity5,032,008266,745 00Mixed
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)04,464,944 00Against
T. Rowe Price2,751,037157,700 00Mixed
Neuberger Berman02,350,523 00Against
Columbia Threadneedle02,340,399 00Against
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds01,843,654 00Against
Eaton Vance01,746,696 00Against
State Street01,608,405 00Against
Invesco01,553,220 00Against
Charles Schwab01,400,493 00Against
Hartford01,393,966 00Against
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent01,293,201 00Against
Waddell & Reed01,256,313 00Against
American Century01,169,630 00Against
JANUS INVESTMENT FUND0878,956 00Against
ALGER FUNDS0735,794 00Against
BNY Mellon641,64536,926 00Mixed
Allspring0632,996 00Against
First Trust0590,995 00Against
Nationwide12,400565,116 00Against

Fund voting reports, all 146 managers: 30,898,591 for, 57,178,781 against, 451,846 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 421 asset managers voting on “APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Lazard011,000,000 00Against
BlackRock52,3794,920,927 00Against
BAMCO INC /NY/04,920,806 00Against
Select Equity Group, L.P.4,511,8830 00For
T. Rowe Price3,596,577291,505 00Mixed
State Street03,794,769 00Against
Neuberger Berman03,728,500 00Against
GEODE CAPITAL MANAGEMENT, LLC3,588,2670 00For
DF DENT & CO INC3,102,5300 00For
MACKENZIE FINANCIAL CORP02,261,875 00Against
Wellington02,215,152 00Against
BROWN CAPITAL MANAGEMENT LLC02,200,587 00Against
ATLANTA CAPITAL MANAGEMENT CO L L C02,076,026 00Against
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC02,004,751 00Against
Fidelity1,852,0710 00For
Invesco01,610,343 00Against
Charles Schwab01,409,282 00Against
Thrivent01,322,082 00Against
Jackson Square Partners, LLC01,143,846 00Against
American Century01,113,278 00Against
Clearbridge Investments, LLC01,073,062 00Against
MELLON INVESTMENTS Corp01,018,170 00Against
Allspring0988,254 00Against
FRED ALGER MANAGEMENT, LLC0971,693 00Against
ArrowMark Colorado Holdings LLC0965,738 00Against

Institutional-manager reports, all 421 managers: 22,222,668 for, 70,682,134 against, 43,989 abstained, 15,893 not voted, 194,771 1 year, 21 unknown. Showing the 25 largest; see all in the interactive database.

12. Approve, on an advisory basis, the frequency of advisory votes on executive compensation to occur every (1) year

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTESSECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

98% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: votes by 300 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 67 asset managers voting on “Approve, on an advisory basis, the frequency of advisory votes on executive compensation to occur every (1) ye” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Neuberger Berman00 00--
TRUST FOR PROFESSIONAL MANAGERS00 00--
Brown Capital Management Mutual Funds00 00--
Charles Schwab00 00--
Hartford00 00--
Advisors' Inner Circle Fund II00 00--
Vanguard00 00--
Bridge Builder Trust00 00--
CARILLON SERIES TRUST00 00--
FORUM FUNDS00 00--
Nationwide00 00--
TOUCHSTONE STRATEGIC TRUST00 00--
Jackson National00 00--
Brighthouse00 8,8180Abstain
Northwestern Mutual00 00--
MERIDIAN FUND INC00 00--
BUFFALO FUNDS00 00--
John Hancock00 00--
VanEck ETF Trust00 00--
Fidelity00 00--
CONESTOGA FUNDS00 00--
Aristotle Funds Series Trust00 00--
Russell Investments00 00--
Global X00 00--
JPMorgan00 00--

Fund voting reports, all 67 managers: 77,689 for, 52,318 abstained, 15,386,776 1 year, 93,073 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 235 asset managers voting on “Approve, on an advisory basis, the frequency of advisory votes on executive compensation to occur every (1) ye” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Select Equity Group, L.P.00 00--
Neuberger Berman00 00--
DF DENT & CO INC00 00--
MACKENZIE FINANCIAL CORP00 00--
Wellington00 00--
BROWN CAPITAL MANAGEMENT LLC00 00--
Charles Schwab00 00Not Voted
ArrowMark Colorado Holdings LLC00 00--
MARSHALL WACE, LLP00 00--
Northern Trust00 00--
RIVERBRIDGE PARTNERS LLC00 00--
Champlain Investment Partners, LLC00 00--
MAIRS & POWER INC00 00--
NEW YORK STATE COMMON RETIREMENT FUND00 00--
AMERICAN CAPITAL MANAGEMENT INC00 00--
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO00 00--
Natixis00 00--
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM00 00--
ENVESTNET ASSET MANAGEMENT INC00 00--
RAYMOND JAMES & ASSOCIATES00 00--
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO00 00--
Broadcrest Asset Management, LLC178,9080 00For
Dorsey & Whitney Trust CO LLC00 00--
VAN ECK ASSOCIATES CORP00 00--
US BANK NATIONAL ASSOCIATION00 00--

Institutional-manager reports, all 235 managers: 283,016 for, 6,473 against, 26,976 abstained, 7,323 not voted, 24,759,349 1 year, 4,511,996 unknown, 22,505 3 year, 113 2 year. Showing the 25 largest; see all in the interactive database.

13. Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) year.

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

14% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: votes by 244 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 91 asset managers voting on “Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) yea” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
WisdomTree32,6260 00For
BlackRock00 00--
Fidelity00 00--
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 00--
T. Rowe Price00 00--
Columbia Threadneedle00 00--
Eaton Vance00 00--
State Street00 00--
Invesco00 00--
Thrivent00 00--
Waddell & Reed00 00--
American Century00 00--
JANUS INVESTMENT FUND00 00--
ALGER FUNDS00 00--
BNY Mellon00 00--
Allspring00 00--
First Trust00 00--
Lincoln Financial00 00--
TIAA00 00--
Royce00 00--
WILLIAM BLAIR FUNDS00 00--
Legg Mason00 00--
Dimensional00 00--
Voya00 00--

Fund voting reports, all 91 managers: 32,626 for, 72,500,736 1 year, 386,000 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 178 asset managers voting on “Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) yea” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Lazard00 00--
BlackRock00 00--
BAMCO INC /NY/00 00--
T. Rowe Price00 00--
State Street00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
ATLANTA CAPITAL MANAGEMENT CO L L C00 00--
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC00 00--
Fidelity00 00--
Invesco00 00--
Thrivent00 00--
Jackson Square Partners, LLC00 00--
American Century00 00--
Clearbridge Investments, LLC00 00--
MELLON INVESTMENTS Corp00 00--
Allspring00 00--
FRED ALGER MANAGEMENT, LLC00 00--
Nikko Asset Management Co., Ltd.00 00--
Newton Investment Management North America, LLC00 00--
EAGLE ASSET MANAGEMENT INC00 00--
Vanguard00 00--
Legal & General Investment Management Ltd00 00--
Stephens Investment Management Group LLC00 00--
PARAMETRIC PORTFOLIO ASSOCIATES LLC00 00--
WESTFIELD CAPITAL MANAGEMENT CO LP00 00--

Institutional-manager reports, all 178 managers: 174 for, 194,747 against, 63,037,688 1 year, 154,511 3 year. Showing the 25 largest; see all in the interactive database.

14. 5. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year…

Official resultFund totals may overlapAUDIT-RELATEDReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%
FOR: 140,734,676AGAINST: 5,247,721
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2024 fiscal year.

BIO-TECHNE CORP.’s own tally for this item (“5. The appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024”): 140,734,676 for, 5,247,721 against — passed, per its Form 8-K filed October 31, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal No. 5 – The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 147 asset managers voting on “Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 202” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For
Nationwide577,5160 00For

Fund voting reports, all 147 managers: 88,550,940 for, 3,704 against, 8,818 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 3 asset managers voting on “Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 202” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
Keel Point, LLC1740 00For
Boltwood Capital Management360 00For

Institutional-manager reports, all 3 managers: 1,476,613 for.

Largest BIO-TECHNE CORP. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 158,354,579 shares outstanding at the time of that meeting.

Fund voting reports: top BIO-TECHNE CORP. shareholders by shares voted on “Election of Directors: Alpna Seth”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 12.15%
2WisdomTree 7.00%
3BlackRock 6.02%
4Fidelity 3.35%
5BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) 2.82%
6T. Rowe Price 1.84%
7Neuberger Berman 1.48%
8Columbia Threadneedle 1.48%
9TRUST FOR PROFESSIONAL MANAGERS 1.22%
10Brown Capital Management Mutual Funds 1.16%
Institutional-manager reports: top BIO-TECHNE CORP. shareholders by shares voted on “APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS.”, 2023-2024
#Asset manager % of shares outstanding
1Lazard 6.95%
2BlackRock 3.14%
3BAMCO INC /NY/ 3.11%
4Select Equity Group, L.P. 2.85%
5T. Rowe Price 2.46%
6State Street 2.40%
7Neuberger Berman 2.35%
8GEODE CAPITAL MANAGEMENT, LLC 2.27%
9DF DENT & CO INC 1.96%
10MACKENZIE FINANCIAL CORP 1.43%

Reported BIO-TECHNE CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

BIO-TECHNE CORP. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Malvern 11.44% DEF14A
Vanguard Group 11.32% 13F
New 9.35% DEF14A
BlackRock 7.51% 13F
Baltimore 5.38% DEF14A
Morgan Stanley 4.57% 13F
State Street 4.02% 13F
T. Rowe Price 3.63% 13F
Geode Capital 2.42% 13F
Invesco 1.97% 13F

Percentages above are of 158,354,579 shares outstanding, as reported by BIO-TECHNE CORP. on its Form 10-Q dated September 30, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIO-TECHNE CORP.’s 10-Q dated September 30, 2023. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At BIO-TECHNE CORP.'s shareholder meeting held October 26, 2023, in the 2023-2024 proxy season, 574 asset managers reported how they voted in their SEC Form N-PX filings, covering 9,959 separate fund positions. Their filings are grouped here into 14 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS. — BIO-TECHNE CORP.'s filing reports the proposal as not approved, with 35% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BIO-TECHNE CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on October 31, 2023.

BIO-TECHNE CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.